Halozyme Therapeutics shares owned by Convergence Investment Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Convergence Investment Partners
from 13F filings
Historical chart of Convergence Investment Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Convergence Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Convergence Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 20k | 73.34 |
| 2025-06-30 | $1.4M | 28k | 52.02 |
| 2025-03-31 | $1.8M | 29k | 63.81 |
| 2024-12-31 | $1.7M | 35k | 47.81 |
| 2024-09-30 | $1.6M | 28k | 57.24 |
| 2024-06-30 | $1.4M | 26k | 52.36 |
| 2015-12-31 | $3.0M | 172k | 17.33 |
| 2015-09-30 | $3.4M | 252k | 13.43 |
More positions owned by Convergence Investment Partners
View all positions for Convergence Investment Partners